FDA approves emergency use for multiplex Zika test

(Columbia University's Mailman School of Public Health) The Center for Infection and Immunity (CII) at Columbia University's Mailman School today announced that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the CII-ArboViroPlex rRT-PCR Test, the first multiplex assay that simultaneously tests for the presence of Zika virus, all serotypes of dengue virus, chikungunya virus, and West Nile virus, as well as a host gene that ensures the accuracy of results.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news